20 results
8-K
EX-99.1
ap34g79
29 Sep 22
GB2064 Shows Reduction in Fibrosis of the Bone Marrow in Patients with Myelofibrosis, Validating LOXL2 as a Clinical Fibrosis Target
7:00am
8-K
EX-99.1
wzxl k4cr
5 Jan 22
Regulation FD Disclosure
4:02pm
10-K
ulfi 0rg52ajnneo0f
29 Mar 21
Annual report
6:03am
8-K
EX-99.1
2ru cixth2r1
5 Jan 21
Results of Operations and Financial Condition
4:31pm
10-Q
emb50m
11 Dec 20
Quarterly report
7:30am
424B4
cfg4sp68ae73j7
30 Oct 20
Prospectus supplement with pricing info
4:31pm
S-1/A
s664ssv
22 Oct 20
IPO registration (amended)
6:13am
S-1
otmn 4lslfmk2xf
7 Oct 20
IPO registration
5:01pm
DRS
46zshs kd
2 Sep 20
Draft registration statement
12:00am
- Prev
- 1
- Next